MARKET

PRFX

PRFX

Painreform Ltd
NASDAQ
0.9606
-0.0594
-5.82%
After Hours: 0.9200 -0.0406 -4.23% 19:54 12/05 EST
OPEN
1.060
PREV CLOSE
1.020
HIGH
1.210
LOW
0.8658
VOLUME
1.50M
TURNOVER
--
52 WEEK HIGH
16.63
52 WEEK LOW
0.8010
MARKET CAP
3.76M
P/E (TTM)
-0.8808
1D
5D
1M
3M
1Y
5Y
1D
PainReform Initiates Phase II Development for OcuRing™-K
TipRanks · 4d ago
PainReform Launches Phase II Trial Development for OcuRing-K Drop-Less Ocular Therapy
Reuters · 4d ago
PainReform commences development plan for OcuRing-K Phase II trial
TipRanks · 4d ago
PainReform Commences Development Plan For OcuRing-K, LayerBio's Patented, Drop-Less, Intraoperatively Administered Sustained-Release Ocular Therapy
Benzinga · 4d ago
BRIEF-Painreform Commences Development For Ocuring™-K Phase II Trial
Reuters · 4d ago
PainReform Advances Drop-Less OcuRing-K Therapy Toward Phase II Trial
Reuters · 4d ago
PainReform Commences Development for OcuRing™-K Phase II Trial, LayerBio’s Drop-Less Sustained-Release Ocular Therapy
Barchart · 4d ago
Weekly Report: what happened at PRFX last week (1124-1128)?
Weekly Report · 5d ago
More
About PRFX
PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.

Webull offers PainReform Ltd stock information, including NASDAQ: PRFX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRFX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PRFX stock methods without spending real money on the virtual paper trading platform.